JP2004533986A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004533986A5 JP2004533986A5 JP2002531973A JP2002531973A JP2004533986A5 JP 2004533986 A5 JP2004533986 A5 JP 2004533986A5 JP 2002531973 A JP2002531973 A JP 2002531973A JP 2002531973 A JP2002531973 A JP 2002531973A JP 2004533986 A5 JP2004533986 A5 JP 2004533986A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- alkoxy
- independently
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL138825A IL138825A (en) | 2000-10-03 | 2000-10-03 | Pharmaceutical preparations containing tryptamine derivatives and similar compounds, and such new compounds |
| PCT/IL2001/000898 WO2002028347A2 (en) | 2000-10-03 | 2001-09-25 | Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004533986A JP2004533986A (ja) | 2004-11-11 |
| JP2004533986A5 true JP2004533986A5 (enExample) | 2008-10-02 |
Family
ID=11074694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002531973A Pending JP2004533986A (ja) | 2000-10-03 | 2001-09-25 | トリプタミン誘導体およびアナログ化合物、ならびにそれらを含有する医薬用処方 |
Country Status (39)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050250794A1 (en) * | 2003-12-19 | 2005-11-10 | Andrew Napper | Methods of treating a disorder |
| MXPA06009377A (es) * | 2004-02-20 | 2007-03-07 | Lifescape Biosciences Inc | Composiciones y metodos para regulacion del sueno. |
| BRPI0611814A2 (pt) * | 2005-06-10 | 2008-12-09 | Bipar Sciences Inc | moduladores parp e tratamento de cÂnceres |
| US7622495B2 (en) | 2006-10-03 | 2009-11-24 | Neurim Pharmaceuticals (1991) Ltd. | Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents |
| DK2173344T3 (en) | 2007-06-29 | 2016-07-25 | Clarencew Pty Ltd | TREATMENT OR PROPHYLAXIS OF NEUROLOGICAL OR NEURO PSYCHIATRIC DISORDERS USING ocular administration |
| PT2291659E (pt) * | 2008-05-13 | 2016-01-22 | Univ Yale | Moléculas quiméricas pequenas para o recrutamento de anticorpos contra células cancerosas |
| US8852630B2 (en) | 2008-05-13 | 2014-10-07 | Yale University | Chimeric small molecules for the recruitment of antibodies to cancer cells |
| CA2837823C (en) | 2011-05-31 | 2023-05-16 | Clarencew Pty. Ltd | Methods for preventing and treating motor-related neurological conditions |
| WO2013063492A1 (en) * | 2011-10-28 | 2013-05-02 | Board Of Regents, The University Of Texas System | Novel compositions and methods for treating cancer |
| CN102816103B (zh) * | 2012-08-20 | 2014-05-07 | 冉瑞琼 | 硫化天冬氨酸修饰的退黑素衍生物及其应用 |
| DK3430022T3 (da) * | 2016-03-14 | 2020-05-18 | Somalogic Inc | Forbindelser og fremgangsmåder til syntese af 5-(N-beskyttet-tryptaminocarboxyamid)-2'-deoxyuridin-phosphoramidit til inkorporering i en nukleinsyresekvens |
| CN116421600B (zh) * | 2023-05-29 | 2024-08-23 | 重庆医科大学 | 色醇在制备治疗焦虑的药物中的应用 |
| WO2025137730A1 (en) * | 2023-12-22 | 2025-06-26 | Alexander Shulgin Research Institute, Inc. | N-substituted tryptamines and n-substituted lysergamides and their use as therapeutic agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL79264A0 (en) * | 1986-06-27 | 1986-09-30 | Univ Ramot | Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors |
| US6310085B1 (en) * | 1997-10-03 | 2001-10-30 | Clarencew Pty Ltd. | Method for the treatment of neurological or neuropsychiatric disorders |
| AUPO274596A0 (en) * | 1996-10-04 | 1996-10-31 | Armstrong, Stuart Maxwell | Method for the treatment of neurological or neuropsychiatric disorders |
-
2000
- 2000-10-03 IL IL138825A patent/IL138825A/en not_active IP Right Cessation
-
2001
- 2001-09-14 TW TW090122940A patent/TWI270544B/zh not_active IP Right Cessation
- 2001-09-25 AU AU9416201A patent/AU9416201A/xx not_active Withdrawn
- 2001-09-25 JP JP2002531973A patent/JP2004533986A/ja active Pending
- 2001-09-25 BR BR0114464-2A patent/BR0114464A/pt not_active Application Discontinuation
- 2001-09-25 PT PT01974651T patent/PT1331935E/pt unknown
- 2001-09-25 PL PL01365679A patent/PL365679A1/xx not_active Application Discontinuation
- 2001-09-25 CA CA2423628A patent/CA2423628C/en not_active Expired - Fee Related
- 2001-09-25 CZ CZ20030940A patent/CZ301098B6/cs not_active IP Right Cessation
- 2001-09-25 US US10/381,976 patent/US6780884B2/en not_active Expired - Fee Related
- 2001-09-25 DK DK01974651T patent/DK1331935T3/da active
- 2001-09-25 UA UA2003043421A patent/UA75091C2/uk unknown
- 2001-09-25 CN CNB018168043A patent/CN100518735C/zh not_active Expired - Fee Related
- 2001-09-25 AT AT01974651T patent/ATE409474T1/de active
- 2001-09-25 EP EP01974651A patent/EP1331935B1/en not_active Expired - Lifetime
- 2001-09-25 SK SK404-2003A patent/SK4042003A3/sk unknown
- 2001-09-25 EE EEP200300135A patent/EE05192B1/xx not_active IP Right Cessation
- 2001-09-25 WO PCT/IL2001/000898 patent/WO2002028347A2/en not_active Ceased
- 2001-09-25 CL CL2001002303A patent/CL2001002303A1/es unknown
- 2001-09-25 ES ES01974651T patent/ES2315307T3/es not_active Expired - Lifetime
- 2001-09-25 DE DE60136003T patent/DE60136003D1/de not_active Expired - Lifetime
- 2001-09-25 KR KR1020037004661A patent/KR100855385B1/ko not_active Expired - Fee Related
- 2001-09-25 MX MXPA03002612A patent/MXPA03002612A/es active IP Right Grant
- 2001-09-25 HU HU0302616A patent/HU227163B1/hu not_active IP Right Cessation
- 2001-09-25 EA EA200300436A patent/EA005918B1/ru not_active IP Right Cessation
- 2001-09-25 UY UY26946A patent/UY26946A1/es not_active Application Discontinuation
- 2001-09-25 AR ARP010104520A patent/AR035587A1/es unknown
- 2001-09-25 SI SI200130889T patent/SI1331935T1/sl unknown
- 2001-09-25 NZ NZ525587A patent/NZ525587A/en unknown
- 2001-09-26 PE PE2001000960A patent/PE20020411A1/es not_active Application Discontinuation
- 2001-09-27 GT GT200100197A patent/GT200100197A/es unknown
- 2001-10-01 PA PA20018529801A patent/PA8529801A1/es unknown
- 2001-10-02 HN HN2001000218A patent/HN2001000218A/es unknown
-
2003
- 2003-03-21 IS IS6752A patent/IS2607B/is unknown
- 2003-03-27 NO NO20031396A patent/NO20031396D0/no not_active Application Discontinuation
- 2003-04-23 ZA ZA200303113A patent/ZA200303113B/xx unknown
- 2003-04-24 BG BG107759A patent/BG107759A/bg unknown
- 2003-05-02 CR CR6968A patent/CR6968A/es unknown
-
2004
- 2004-08-20 US US10/921,823 patent/US20050020664A1/en not_active Abandoned
-
2008
- 2008-12-22 CY CY20081101480T patent/CY1110417T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2336275C2 (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью, и фармацевтическая композиция | |
| JP2008509187A5 (enExample) | ||
| JP2001526218A5 (enExample) | ||
| JP2004526788A5 (enExample) | ||
| JPH11193282A5 (enExample) | ||
| RU2007101685A (ru) | Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения | |
| JP2004529114A5 (enExample) | ||
| JP2003519228A5 (enExample) | ||
| JP2024507414A5 (enExample) | ||
| JP2012131829A (ja) | そう痒状態の処置のためのｍｇｌｕｒ５アンタゴニストの使用 | |
| JP2003517460A5 (enExample) | ||
| US20220062279A1 (en) | Treatment of movement disorders | |
| JP2002535370A5 (enExample) | ||
| JP2019524797A5 (enExample) | ||
| JP2024540030A (ja) | 修飾インドール化合物 | |
| CA2423628A1 (en) | Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them | |
| CA2374158A1 (en) | Indole derivatives | |
| JP2013538218A5 (enExample) | ||
| JP3096306B2 (ja) | 新規な治療方法 | |
| JP2002520315A5 (enExample) | ||
| JP2004536079A5 (enExample) | ||
| RU2003101396A (ru) | Замещенные нитрированные катехолы, их применение в лечении некоторых расстройств центральной и периферической нервной системы и содержащие их фармацевтические композиции | |
| JP2004522781A5 (enExample) | ||
| CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
| JP2003516994A5 (enExample) |